[
  {
    "": 0,
    "Gene name": "BRCA1",
    "Genomic Position": "17:41197646-41277500(-)",
    "CDS Mutation": "unspecified_and_ERBB2_unspecified",
    "AA Mutation": "unspecified_and_ERBB2_unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Carboplatin + Olaparib + Paclitaxel + Pembrolizumab",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT05485766"
  },
  {
    "": 1,
    "Gene name": "BRCA1",
    "Genomic Position": "17:41197646-41277500(-)",
    "CDS Mutation": "unspecified_or_BRCA2_unspecified",
    "AA Mutation": "unspecified_or_BRCA2_unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Carboplatin + Olaparib + Paclitaxel + Pembrolizumab",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT05485766"
  },
  {
    "": 2,
    "Gene name": "BRCA1",
    "Genomic Position": "17:41197646-41277500(-)",
    "CDS Mutation": "Mutation",
    "AA Mutation": "Mutation",
    "Disease": "Triple-receptor Negative Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Carboplatin + Olaparib + Paclitaxel + Pembrolizumab",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT05485766"
  },
  {
    "": 3,
    "Gene name": "BRCA1",
    "Genomic Position": "17:41197646-41277500(-)",
    "CDS Mutation": "unspecified_or_BRCA2_unspecified",
    "AA Mutation": "unspecified_or_BRCA2_unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Carboplatin + Olaparib + Paclitaxel + Pembrolizumab",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT05485766"
  },
  {
    "": 4,
    "Gene name": "BRCA1",
    "Genomic Position": "17:41197646-41277500(-)",
    "CDS Mutation": "unspecified_or_BRCA2_unspecified",
    "AA Mutation": "unspecified_or_BRCA2_unspecified",
    "Disease": "breast / carcinoma / basal (triple-negative) carcinoma",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Carboplatin + Olaparib + Paclitaxel + Pembrolizumab",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT05485766"
  },
  {
    "": 5,
    "Gene name": "BRCA1",
    "Genomic Position": "17:41197646-41277500(-)",
    "CDS Mutation": "unspecified_or_BRCA2_unspecified_or_PALB2_unspecified_or_RAD51C_unspecified_or_RAD51D_unspecified",
    "AA Mutation": "unspecified_or_BRCA2_unspecified_or_PALB2_unspecified_or_RAD51C_unspecified_or_RAD51D_unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Carboplatin + Olaparib + Paclitaxel + Pembrolizumab",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT05485766"
  },
  {
    "": 6,
    "Gene name": "BRCA1",
    "Genomic Position": "17:41197646-41277500(-)",
    "CDS Mutation": "unspecified_or_BRCA2_unspecified_or_PALB2_unspecified",
    "AA Mutation": "unspecified_or_BRCA2_unspecified_or_PALB2_unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Carboplatin + Olaparib + Paclitaxel + Pembrolizumab",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT05485766"
  },
  {
    "": 7,
    "Gene name": "BRCA1",
    "Genomic Position": "17:41197646-41277500(-)",
    "CDS Mutation": "unspecified_or_BRCA2_unspecified_or_CHEK2_unspecified_or_PALB2_unspecified",
    "AA Mutation": "unspecified_or_BRCA2_unspecified_or_CHEK2_unspecified_or_PALB2_unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Carboplatin + Olaparib + Paclitaxel + Pembrolizumab",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT05485766"
  },
  {
    "": 8,
    "Gene name": "BRCA1",
    "Genomic Position": "17:41197646-41277500(-)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Carboplatin + Olaparib + Paclitaxel + Pembrolizumab",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT05485766"
  },
  {
    "": 9,
    "Gene name": "BRCA1",
    "Genomic Position": "17:41197646-41277500(-)",
    "CDS Mutation": "Mutation",
    "AA Mutation": "Mutation",
    "Disease": "Her2-receptor Negative Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Carboplatin + Olaparib + Paclitaxel + Pembrolizumab",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT05485766"
  },
  {
    "": 10,
    "Gene name": "BRCA1",
    "Genomic Position": "17:41197646-41277500(-)",
    "CDS Mutation": "Loss-of-function",
    "AA Mutation": "Loss-of-function",
    "Disease": "Her2-receptor Negative Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Carboplatin + Olaparib + Paclitaxel + Pembrolizumab",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT05485766"
  },
  {
    "": 11,
    "Gene name": "BRCA1",
    "Genomic Position": "17:41197646-41277500(-)",
    "CDS Mutation": "Loss-of-function",
    "AA Mutation": "Loss-of-function",
    "Disease": "Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Carboplatin + Olaparib + Paclitaxel + Pembrolizumab",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT05485766"
  },
  {
    "": 12,
    "Gene name": "BRCA1",
    "Genomic Position": "17:41197646-41277500(-)",
    "CDS Mutation": "Mutation",
    "AA Mutation": "Mutation",
    "Disease": "Triple-receptor Negative Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Resistance",
    "Therapies": "Carboplatin + Olaparib + Paclitaxel + Pembrolizumab",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT05485766"
  },
  {
    "": 13,
    "Gene name": "AKT2",
    "Genomic Position": "19:40736224-40791302(-)",
    "CDS Mutation": "EXPRESSION",
    "AA Mutation": "EXPRESSION",
    "Disease": "Breast Cancer",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Trastuzumab",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:22842582"
  },
  {
    "": 14,
    "Gene name": "ERBB2",
    "Genomic Position": "17:37856333-37884915(+)",
    "CDS Mutation": "Amplification",
    "AA Mutation": "Amplification",
    "Disease": "Her2-receptor Positive Breast Cancer",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Trastuzumab",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:31867841"
  },
  {
    "": 15,
    "Gene name": "ERBB2",
    "Genomic Position": "17:37856333-37884915(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Trastuzumab",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:31867841"
  },
  {
    "": 16,
    "Gene name": "ERBB2",
    "Genomic Position": "17:37856333-37884915(+)",
    "CDS Mutation": "unspecified_and_WT1_unspecified",
    "AA Mutation": "unspecified_and_WT1_unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Trastuzumab",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:31867841"
  },
  {
    "": 17,
    "Gene name": "ERBB2",
    "Genomic Position": "17:37856333-37884915(+)",
    "CDS Mutation": "unspecified_and_(PIK3CA_Exon9_or_PIK3CA_Exon20)_",
    "AA Mutation": "unspecified_and_(PIK3CA_Exon9_or_PIK3CA_Exon20)_",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Trastuzumab",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:31867841"
  },
  {
    "": 18,
    "Gene name": "ERBB2",
    "Genomic Position": "17:37856333-37884915(+)",
    "CDS Mutation": "unspecified_and_ESR1_unspecified",
    "AA Mutation": "unspecified_and_ESR1_unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Trastuzumab",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:31867841"
  },
  {
    "": 19,
    "Gene name": "ERBB2",
    "Genomic Position": "17:37856333-37884915(+)",
    "CDS Mutation": "unspecified_and_GATA3_unspecified",
    "AA Mutation": "unspecified_and_GATA3_unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Trastuzumab",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:31867841"
  },
  {
    "": 20,
    "Gene name": "ERBB2",
    "Genomic Position": "17:37856333-37884915(+)",
    "CDS Mutation": "unspecified_and_PIK3CA_unspecified",
    "AA Mutation": "unspecified_and_PIK3CA_unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Trastuzumab",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:31867841"
  },
  {
    "": 21,
    "Gene name": "ERBB2",
    "Genomic Position": "17:37856333-37884915(+)",
    "CDS Mutation": "unspecified_and_PTEN_unspecified",
    "AA Mutation": "unspecified_and_PTEN_unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Trastuzumab",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:31867841"
  },
  {
    "": 22,
    "Gene name": "ERBB2",
    "Genomic Position": "17:37856333-37884915(+)",
    "CDS Mutation": "unspecified_and_TBX3_unspecified",
    "AA Mutation": "unspecified_and_TBX3_unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Trastuzumab",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:31867841"
  },
  {
    "": 23,
    "Gene name": "ERBB2",
    "Genomic Position": "17:37856333-37884915(+)",
    "CDS Mutation": "unspecified_and_TOP2A_unspecified",
    "AA Mutation": "unspecified_and_TOP2A_unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Trastuzumab",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:31867841"
  },
  {
    "": 24,
    "Gene name": "ERBB2",
    "Genomic Position": "17:37856333-37884915(+)",
    "CDS Mutation": "unspecified_and_TP53_unspecified",
    "AA Mutation": "unspecified_and_TP53_unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Trastuzumab",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:31867841"
  },
  {
    "": 25,
    "Gene name": "ERBB2",
    "Genomic Position": "17:37856333-37884915(+)",
    "CDS Mutation": "unspecified_and_TP53_unspecified_",
    "AA Mutation": "unspecified_and_TP53_unspecified_",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Trastuzumab",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:31867841"
  },
  {
    "": 26,
    "Gene name": "ERBB2",
    "Genomic Position": "17:37856333-37884915(+)",
    "CDS Mutation": "Overexpression",
    "AA Mutation": "Overexpression",
    "Disease": "Her2-receptor Positive Breast Cancer",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Trastuzumab",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:31867841"
  },
  {
    "": 27,
    "Gene name": "ERBB2",
    "Genomic Position": "17:37856333-37884915(+)",
    "CDS Mutation": "SERUM_LEVELS",
    "AA Mutation": "SERUM_LEVELS",
    "Disease": "Breast Cancer",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Trastuzumab",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:31867841"
  },
  {
    "": 28,
    "Gene name": "ERBB2",
    "Genomic Position": "17:37856333-37884915(+)",
    "CDS Mutation": "unspecified_and_ERBB2_unspecified",
    "AA Mutation": "unspecified_and_ERBB2_unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Trastuzumab",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:31867841"
  },
  {
    "": 29,
    "Gene name": "ERBB2",
    "Genomic Position": "17:37856333-37884915(+)",
    "CDS Mutation": "Exon19,Exon20",
    "AA Mutation": "Exon19,Exon20",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Trastuzumab",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:31867841"
  },
  {
    "": 30,
    "Gene name": "ERBB2",
    "Genomic Position": "17:37856333-37884915(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 2,
    "Response to Drug": "Sensitivity",
    "Therapies": "Trastuzumab",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:31867841"
  },
  {
    "": 31,
    "Gene name": "ERBB2",
    "Genomic Position": "17:37856333-37884915(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Trastuzumab",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:31867841"
  },
  {
    "": 32,
    "Gene name": "ERBB2",
    "Genomic Position": "17:37856333-37884915(+)",
    "CDS Mutation": "Amplification",
    "AA Mutation": "Amplification",
    "Disease": "Her2-receptor Positive Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Trastuzumab",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:31867841"
  },
  {
    "": 33,
    "Gene name": "ERBB2",
    "Genomic Position": "17:37856333-37884915(+)",
    "CDS Mutation": "Mutation",
    "AA Mutation": "Mutation",
    "Disease": "Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Trastuzumab",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:31867841"
  },
  {
    "": 34,
    "Gene name": "ERBB2",
    "Genomic Position": "17:37856333-37884915(+)",
    "CDS Mutation": "unspecified_and_NRG1_unspecified",
    "AA Mutation": "unspecified_and_NRG1_unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Trastuzumab",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:31867841"
  },
  {
    "": 35,
    "Gene name": "ERBB2",
    "Genomic Position": "17:37856333-37884915(+)",
    "CDS Mutation": "unspecified_and_ERBB3_unspecified",
    "AA Mutation": "unspecified_and_ERBB3_unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Trastuzumab",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:31867841"
  },
  {
    "": 36,
    "Gene name": "ERBB2",
    "Genomic Position": "17:37856333-37884915(+)",
    "CDS Mutation": "unspecified_and_PIK3CA_unspecified",
    "AA Mutation": "unspecified_and_PIK3CA_unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Trastuzumab",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:31867841"
  },
  {
    "": 37,
    "Gene name": "ERBB2",
    "Genomic Position": "17:37856333-37884915(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma in situ / ductal carcinoma in situ",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Trastuzumab",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:31867841"
  },
  {
    "": 38,
    "Gene name": "ERBB2",
    "Genomic Position": "17:37856333-37884915(+)",
    "CDS Mutation": "c.2516T>G",
    "AA Mutation": "p.L839R",
    "Disease": "ductal_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Trastuzumab",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:31867841"
  },
  {
    "": 39,
    "Gene name": "ERBB2",
    "Genomic Position": "17:37856333-37884915(+)",
    "CDS Mutation": "c.2606T>G",
    "AA Mutation": "p.L869R",
    "Disease": "ductal_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Trastuzumab",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:31867841"
  },
  {
    "": 40,
    "Gene name": "ERBB2",
    "Genomic Position": "17:37856333-37884915(+)",
    "CDS Mutation": "c.1778T>G",
    "AA Mutation": "p.L593R",
    "Disease": "ductal_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Trastuzumab",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:31867841"
  },
  {
    "": 41,
    "Gene name": "ERBB2",
    "Genomic Position": "17:37856333-37884915(+)",
    "CDS Mutation": "c.2561T>G",
    "AA Mutation": "p.L854R",
    "Disease": "ductal_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Trastuzumab",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:31867841"
  },
  {
    "": 42,
    "Gene name": "RB1",
    "Genomic Position": "13:48877911-49056122(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Alpelisib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:25002028"
  },
  {
    "": 43,
    "Gene name": "RB1",
    "Genomic Position": "13:48877911-49056122(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / basal (triple-negative) carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Alpelisib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:25002028"
  },
  {
    "": 44,
    "Gene name": "RB1",
    "Genomic Position": "13:48877911-49056122(+)",
    "CDS Mutation": "PHOSPHORYLATION",
    "AA Mutation": "p.PHOSPHORYLATION",
    "Disease": "Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Resistance",
    "Therapies": "Alpelisib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:25002028"
  },
  {
    "": 45,
    "Gene name": "NF2",
    "Genomic Position": "22:29999547-30094587(+)",
    "CDS Mutation": "K159fs",
    "AA Mutation": "p.K159fs",
    "Disease": "Breast Cancer",
    "therapy_rank": 4,
    "Response to Drug": "Sensitivity",
    "Therapies": "Temsirolimus",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:25878190"
  },
  {
    "": 46,
    "Gene name": "GK",
    "Genomic Position": "X:30671476-30748725(+)",
    "CDS Mutation": "Overexpression",
    "AA Mutation": "Overexpression",
    "Disease": "Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Resistance",
    "Therapies": "Alpelisib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:27451907"
  },
  {
    "": 47,
    "Gene name": "IGF1",
    "Genomic Position": "12:102811269-102874341(-)",
    "CDS Mutation": "Overexpression",
    "AA Mutation": "Overexpression",
    "Disease": "Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Metformin,Exemestane",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26706833"
  },
  {
    "": 48,
    "Gene name": "IGF1R",
    "Genomic Position": "15:99192200-99507759(+)",
    "CDS Mutation": "Overexpression",
    "AA Mutation": "Overexpression",
    "Disease": "Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Metformin,Exemestane",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26706833"
  },
  {
    "": 49,
    "Gene name": "TUBB3",
    "Genomic Position": "16:89989687-90002505(+)",
    "CDS Mutation": "EXPRESSION",
    "AA Mutation": "EXPRESSION",
    "Disease": "Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Taxane Compound",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:23218766"
  },
  {
    "": 50,
    "Gene name": "CCND1",
    "Genomic Position": "11:69455855-69469242(+)",
    "CDS Mutation": "unspecified_or_CCND2_unspecified",
    "AA Mutation": "unspecified_or_CCND2_unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Eribulin",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT04683445"
  },
  {
    "": 51,
    "Gene name": "CCND1",
    "Genomic Position": "11:69455855-69469242(+)",
    "CDS Mutation": "unspecified_or_CDKN2A_unspecified_or_CDK4_unspecified_or_CDK6_unspecified",
    "AA Mutation": "unspecified_or_CDKN2A_unspecified_or_CDK4_unspecified_or_CDK6_unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Eribulin",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT04683445"
  },
  {
    "": 52,
    "Gene name": "CCND1",
    "Genomic Position": "11:69455855-69469242(+)",
    "CDS Mutation": "unspecified_or_ESR1_unspecified_or_PGR_unspecified",
    "AA Mutation": "unspecified_or_ESR1_unspecified_or_PGR_unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Eribulin",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT04683445"
  },
  {
    "": 53,
    "Gene name": "CCND1",
    "Genomic Position": "11:69455855-69469242(+)",
    "CDS Mutation": "Overexpression",
    "AA Mutation": "Overexpression",
    "Disease": "Estrogen-receptor Positive Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Resistance",
    "Therapies": "Eribulin",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT04683445"
  },
  {
    "": 54,
    "Gene name": "CCND1",
    "Genomic Position": "11:69455855-69469242(+)",
    "CDS Mutation": "unspecified_or_CDKN2A_unspecified_or_ESR1_unspecified_or_PIK3CA_unspecified_or_PTEN_unspecified_or_TP53_unspecified_or_RB1_unspecified",
    "AA Mutation": "unspecified_or_CDKN2A_unspecified_or_ESR1_unspecified_or_PIK3CA_unspecified_or_PTEN_unspecified_or_TP53_unspecified_or_RB1_unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Eribulin",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT04683445"
  },
  {
    "": 55,
    "Gene name": "CCND1",
    "Genomic Position": "11:69455855-69469242(+)",
    "CDS Mutation": "unspecified_or_ERBB2_unspecified_or_ERBB4_unspecified_or_PIK3CA_unspecified_or_TP53_unspecified",
    "AA Mutation": "unspecified_or_ERBB2_unspecified_or_ERBB4_unspecified_or_PIK3CA_unspecified_or_TP53_unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 4,
    "Response to Drug": "Sensitivity",
    "Therapies": "Eribulin",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT04683445"
  },
  {
    "": 56,
    "Gene name": "FOXP3",
    "Genomic Position": "X:49106897-49121288(-)",
    "CDS Mutation": "EXPRESSION",
    "AA Mutation": "EXPRESSION",
    "Disease": "Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Epirubicin",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:22431701"
  },
  {
    "": 57,
    "Gene name": "TFF3",
    "Genomic Position": "21:43731777-43735761(-)",
    "CDS Mutation": "EXPRESSION",
    "AA Mutation": "EXPRESSION",
    "Disease": "Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Aminoglutethimide,Tamoxifen",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:25900183"
  },
  {
    "": 58,
    "Gene name": "BIRC5",
    "Genomic Position": "17:76210267-76221717(+)",
    "CDS Mutation": "Overexpression",
    "AA Mutation": "Overexpression",
    "Disease": "Her2-receptor Positive Breast Cancer",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Trastuzumab",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:23204226"
  },
  {
    "": 59,
    "Gene name": "UBB",
    "Genomic Position": "17:16284113-16286054(+)",
    "CDS Mutation": "EXPRESSION",
    "AA Mutation": "EXPRESSION",
    "Disease": "Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Taxane Compound",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:23218766"
  },
  {
    "": 60,
    "Gene name": "FGFR1",
    "Genomic Position": "8:38268656-38325363(-)",
    "CDS Mutation": "unspecified_or_FGFR2_unspecified_or_FGFR3_unspecified_or_FGFR4_unspecified",
    "AA Mutation": "unspecified_or_FGFR2_unspecified_or_FGFR3_unspecified_or_FGFR4_unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Palbociclib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:30914635"
  },
  {
    "": 61,
    "Gene name": "FGFR1",
    "Genomic Position": "8:38268656-38325363(-)",
    "CDS Mutation": "Amplification",
    "AA Mutation": "Amplification",
    "Disease": "Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Palbociclib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:30914635"
  },
  {
    "": 62,
    "Gene name": "FGFR1",
    "Genomic Position": "8:38268656-38325363(-)",
    "CDS Mutation": "unspecified_or_FGFR2_unspecified_or_FGFR3_unspecified",
    "AA Mutation": "unspecified_or_FGFR2_unspecified_or_FGFR3_unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Palbociclib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:30914635"
  },
  {
    "": 63,
    "Gene name": "FGFR1",
    "Genomic Position": "8:38268656-38325363(-)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Palbociclib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:30914635"
  },
  {
    "": 64,
    "Gene name": "FGFR1",
    "Genomic Position": "8:38268656-38325363(-)",
    "CDS Mutation": "unspecified_or_FGFR2_unspecified_or_FGFR3_unspecified_or_FGFR4_unspecified",
    "AA Mutation": "unspecified_or_FGFR2_unspecified_or_FGFR3_unspecified_or_FGFR4_unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Palbociclib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:30914635"
  },
  {
    "": 65,
    "Gene name": "FGFR1",
    "Genomic Position": "8:38268656-38325363(-)",
    "CDS Mutation": "Amplification",
    "AA Mutation": "Amplification",
    "Disease": "Breast Cancer",
    "therapy_rank": 4,
    "Response to Drug": "Sensitivity",
    "Therapies": "Palbociclib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:30914635"
  },
  {
    "": 66,
    "Gene name": "FGFR1",
    "Genomic Position": "8:38268656-38325363(-)",
    "CDS Mutation": "c.1608C>A",
    "AA Mutation": "p.N536K",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Palbociclib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:30914635"
  },
  {
    "": 67,
    "Gene name": "FGFR1",
    "Genomic Position": "8:38268656-38325363(-)",
    "CDS Mutation": "c.1365C>A",
    "AA Mutation": "p.N455K",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Palbociclib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:30914635"
  },
  {
    "": 68,
    "Gene name": "FGFR1",
    "Genomic Position": "8:38268656-38325363(-)",
    "CDS Mutation": "c.1632C>A",
    "AA Mutation": "p.N544K",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Palbociclib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:30914635"
  },
  {
    "": 69,
    "Gene name": "FGFR1",
    "Genomic Position": "8:38268656-38325363(-)",
    "CDS Mutation": "c.1731C>A",
    "AA Mutation": "p.N577K",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Palbociclib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:30914635"
  },
  {
    "": 70,
    "Gene name": "FGFR1",
    "Genomic Position": "8:38268656-38325363(-)",
    "CDS Mutation": "c.1371C>A",
    "AA Mutation": "p.N457K",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Palbociclib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:30914635"
  },
  {
    "": 71,
    "Gene name": "FGFR1",
    "Genomic Position": "8:38268656-38325363(-)",
    "CDS Mutation": "c.*688C>A",
    "AA Mutation": "p.?",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Palbociclib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:30914635"
  },
  {
    "": 72,
    "Gene name": "FGFR1",
    "Genomic Position": "8:38268656-38325363(-)",
    "CDS Mutation": "c.1638C>A",
    "AA Mutation": "p.N546K",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Palbociclib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:30914635"
  },
  {
    "": 73,
    "Gene name": "FGFR1",
    "Genomic Position": "8:38268656-38325363(-)",
    "CDS Mutation": "c.*533C>A",
    "AA Mutation": "p.?",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Palbociclib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:30914635"
  },
  {
    "": 74,
    "Gene name": "CA1",
    "Genomic Position": "8:86239837-86291243(-)",
    "CDS Mutation": "Mutation",
    "AA Mutation": "Mutation",
    "Disease": "Triple-receptor Negative Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Olaparib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:28792849"
  },
  {
    "": 75,
    "Gene name": "CA1",
    "Genomic Position": "8:86239837-86291243(-)",
    "CDS Mutation": "Mutation",
    "AA Mutation": "Mutation",
    "Disease": "Triple-receptor Negative Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Resistance",
    "Therapies": "Olaparib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:28792849"
  },
  {
    "": 76,
    "Gene name": "CA1",
    "Genomic Position": "8:86239837-86291243(-)",
    "CDS Mutation": "Loss-of-function",
    "AA Mutation": "Loss-of-function",
    "Disease": "Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Olaparib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:28792849"
  },
  {
    "": 77,
    "Gene name": "CA1",
    "Genomic Position": "8:86239837-86291243(-)",
    "CDS Mutation": "Loss-of-function",
    "AA Mutation": "Loss-of-function",
    "Disease": "Her2-receptor Negative Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Olaparib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:28792849"
  },
  {
    "": 78,
    "Gene name": "CA1",
    "Genomic Position": "8:86239837-86291243(-)",
    "CDS Mutation": "Mutation",
    "AA Mutation": "Mutation",
    "Disease": "Her2-receptor Negative Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Olaparib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:28792849"
  },
  {
    "": 79,
    "Gene name": "IK",
    "Genomic Position": "5:140027355-140042063(+)",
    "CDS Mutation": "Mutation",
    "AA Mutation": "Mutation",
    "Disease": "Her2-receptor Positive Breast Cancer",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Fulvestrant,Everolimus",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:27445490"
  },
  {
    "": 80,
    "Gene name": "IK",
    "Genomic Position": "5:140027355-140042063(+)",
    "CDS Mutation": "Mutation",
    "AA Mutation": "Mutation",
    "Disease": "Breast Cancer",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Fulvestrant,Everolimus",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:27445490"
  },
  {
    "": 81,
    "Gene name": "IK",
    "Genomic Position": "5:140027355-140042063(+)",
    "CDS Mutation": "Mutation",
    "AA Mutation": "Mutation",
    "Disease": "Her2-receptor Positive Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Fulvestrant,Everolimus",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:27445490"
  },
  {
    "": 82,
    "Gene name": "IK",
    "Genomic Position": "5:140027355-140042063(+)",
    "CDS Mutation": "Mutation",
    "AA Mutation": "Mutation",
    "Disease": "Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Fulvestrant,Everolimus",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:27445490"
  },
  {
    "": 83,
    "Gene name": "IK",
    "Genomic Position": "5:140027355-140042063(+)",
    "CDS Mutation": "c.1624G>A",
    "AA Mutation": "p.E542K",
    "Disease": "Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Fulvestrant,Everolimus",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:27445490"
  },
  {
    "": 84,
    "Gene name": "IK",
    "Genomic Position": "5:140027355-140042063(+)",
    "CDS Mutation": "H1047X",
    "AA Mutation": "p.H1047X",
    "Disease": "Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Fulvestrant,Everolimus",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:27445490"
  },
  {
    "": 85,
    "Gene name": "IK",
    "Genomic Position": "5:140027355-140042063(+)",
    "CDS Mutation": "c.1634A>G",
    "AA Mutation": "p.E545",
    "Disease": "Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Fulvestrant,Everolimus",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:27445490"
  },
  {
    "": 86,
    "Gene name": "IK",
    "Genomic Position": "5:140027355-140042063(+)",
    "CDS Mutation": "c.3140A>G",
    "AA Mutation": "p.H1047R",
    "Disease": "Her2-receptor Positive Breast Cancer",
    "therapy_rank": 4,
    "Response to Drug": "Sensitivity",
    "Therapies": "Fulvestrant,Everolimus",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:27445490"
  },
  {
    "": 87,
    "Gene name": "TUBB",
    "Genomic Position": "6:30687978-30693203(+)",
    "CDS Mutation": "EXPRESSION",
    "AA Mutation": "EXPRESSION",
    "Disease": "Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Taxane Compound",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:23218766"
  },
  {
    "": 88,
    "Gene name": "SF1",
    "Genomic Position": "11:64532078-64545941(-)",
    "CDS Mutation": "Amplification",
    "AA Mutation": "Amplification",
    "Disease": "Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Resistance",
    "Therapies": "Tamoxifen",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:24367492"
  },
  {
    "": 89,
    "Gene name": "FGF3",
    "Genomic Position": "11:69624992-69633792(-)",
    "CDS Mutation": "Amplification",
    "AA Mutation": "Amplification",
    "Disease": "Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Dovitinib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:23658459"
  },
  {
    "": 90,
    "Gene name": "CDKN2A",
    "Genomic Position": "9:21968055-21974865(-)",
    "CDS Mutation": "Loss",
    "AA Mutation": "Loss",
    "Disease": "Her2-receptor Negative Breast Cancer",
    "therapy_rank": 4,
    "Response to Drug": "Sensitivity",
    "Therapies": "Letrozole,Palbociclib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26715889"
  },
  {
    "": 91,
    "Gene name": "TIMP1",
    "Genomic Position": "X:47441712-47446188(+)",
    "CDS Mutation": "Overexpression",
    "AA Mutation": "Overexpression",
    "Disease": "Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Resistance",
    "Therapies": "Paclitaxel",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:22544540"
  },
  {
    "": 92,
    "Gene name": "PIK3CA",
    "Genomic Position": "3:178866311-178957881(+)",
    "CDS Mutation": "Mutation",
    "AA Mutation": "Mutation",
    "Disease": "Her2-receptor Positive Breast Cancer",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Fulvestrant,Everolimus",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:27445490"
  },
  {
    "": 93,
    "Gene name": "PIK3CA",
    "Genomic Position": "3:178866311-178957881(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Fulvestrant,Everolimus",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:27445490"
  },
  {
    "": 94,
    "Gene name": "PIK3CA",
    "Genomic Position": "3:178866311-178957881(+)",
    "CDS Mutation": "unspecified_or_PTEN_unspecified_or_TP53_unspecified",
    "AA Mutation": "unspecified_or_PTEN_unspecified_or_TP53_unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Fulvestrant,Everolimus",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:27445490"
  },
  {
    "": 95,
    "Gene name": "PIK3CA",
    "Genomic Position": "3:178866311-178957881(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / basal (triple-negative) carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Fulvestrant,Everolimus",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:27445490"
  },
  {
    "": 96,
    "Gene name": "PIK3CA",
    "Genomic Position": "3:178866311-178957881(+)",
    "CDS Mutation": "c.3140A>G",
    "AA Mutation": "p.H1047R",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Fulvestrant,Everolimus",
    "Description": "",
    "rs value": 121913279,
    "pmid": "PubMed:27445490"
  },
  {
    "": 97,
    "Gene name": "PIK3CA",
    "Genomic Position": "3:178866311-178957881(+)",
    "CDS Mutation": "Mutation",
    "AA Mutation": "Mutation",
    "Disease": "Breast Cancer",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Fulvestrant,Everolimus",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:27445490"
  },
  {
    "": 98,
    "Gene name": "PIK3CA",
    "Genomic Position": "3:178866311-178957881(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Fulvestrant,Everolimus",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:27445490"
  },
  {
    "": 99,
    "Gene name": "PIK3CA",
    "Genomic Position": "3:178866311-178957881(+)",
    "CDS Mutation": "c.1634A>G",
    "AA Mutation": "p.E545",
    "Disease": "Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Fulvestrant,Everolimus",
    "Description": "",
    "rs value": 121913274,
    "pmid": "PubMed:27445490"
  },
  {
    "": 100,
    "Gene name": "PIK3CA",
    "Genomic Position": "3:178866311-178957881(+)",
    "CDS Mutation": "H1047X",
    "AA Mutation": "p.H1047X",
    "Disease": "Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Fulvestrant,Everolimus",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:27445490"
  },
  {
    "": 101,
    "Gene name": "PIK3CA",
    "Genomic Position": "3:178866311-178957881(+)",
    "CDS Mutation": "c.1624G>A",
    "AA Mutation": "p.E542K",
    "Disease": "Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Fulvestrant,Everolimus",
    "Description": "",
    "rs value": 121913273,
    "pmid": "PubMed:27445490"
  },
  {
    "": 102,
    "Gene name": "PIK3CA",
    "Genomic Position": "3:178866311-178957881(+)",
    "CDS Mutation": "unspecified_or_PTEN_unspecified",
    "AA Mutation": "unspecified_or_PTEN_unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Fulvestrant,Everolimus",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:27445490"
  },
  {
    "": 103,
    "Gene name": "PIK3CA",
    "Genomic Position": "3:178866311-178957881(+)",
    "CDS Mutation": "Mutation",
    "AA Mutation": "Mutation",
    "Disease": "Her2-receptor Positive Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Fulvestrant,Everolimus",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:27445490"
  },
  {
    "": 104,
    "Gene name": "PIK3CA",
    "Genomic Position": "3:178866311-178957881(+)",
    "CDS Mutation": "Mutation",
    "AA Mutation": "Mutation",
    "Disease": "Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Fulvestrant,Everolimus",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:27445490"
  },
  {
    "": 105,
    "Gene name": "PIK3CA",
    "Genomic Position": "3:178866311-178957881(+)",
    "CDS Mutation": "Exon9_or_PIK3CA_Exon20",
    "AA Mutation": "Exon9_or_PIK3CA_Exon20",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Fulvestrant,Everolimus",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:27445490"
  },
  {
    "": 106,
    "Gene name": "PIK3CA",
    "Genomic Position": "3:178866311-178957881(+)",
    "CDS Mutation": "c.3140A>G",
    "AA Mutation": "p.H1047R",
    "Disease": "Her2-receptor Positive Breast Cancer",
    "therapy_rank": 4,
    "Response to Drug": "Sensitivity",
    "Therapies": "Fulvestrant,Everolimus",
    "Description": "",
    "rs value": 121913279,
    "pmid": "PubMed:27445490"
  },
  {
    "": 107,
    "Gene name": "SGK1",
    "Genomic Position": "6:134490384-134639196(-)",
    "CDS Mutation": "Overexpression",
    "AA Mutation": "Overexpression",
    "Disease": "Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Resistance",
    "Therapies": "Alpelisib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:27451907"
  },
  {
    "": 108,
    "Gene name": "TP53",
    "Genomic Position": "17:7571720-7590856(-)",
    "CDS Mutation": "c.745A>T",
    "AA Mutation": "p.R249",
    "Disease": "Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Tamoxifen",
    "Description": "",
    "rs value": 587782082,
    "pmid": "PubMed:10786679"
  },
  {
    "": 109,
    "Gene name": "TP53",
    "Genomic Position": "17:7571720-7590856(-)",
    "CDS Mutation": "DNA_Binding_Domain_Mutation",
    "AA Mutation": "DNA_Binding_Domain_Mutation",
    "Disease": "Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Resistance",
    "Therapies": "Tamoxifen",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:10786679"
  },
  {
    "": 110,
    "Gene name": "TP53",
    "Genomic Position": "17:7571720-7590856(-)",
    "CDS Mutation": "deletion_and_PDCD4_unspecified",
    "AA Mutation": "deletion_and_PDCD4_unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Tamoxifen",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:10786679"
  },
  {
    "": 111,
    "Gene name": "TP53",
    "Genomic Position": "17:7571720-7590856(-)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Tamoxifen",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:10786679"
  },
  {
    "": 112,
    "Gene name": "TP53",
    "Genomic Position": "17:7571720-7590856(-)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / basal (triple-negative) carcinoma",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Tamoxifen",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:10786679"
  },
  {
    "": 113,
    "Gene name": "TP53",
    "Genomic Position": "17:7571720-7590856(-)",
    "CDS Mutation": "Mutation",
    "AA Mutation": "Mutation",
    "Disease": "Breast Cancer",
    "therapy_rank": 4,
    "Response to Drug": "Resistance",
    "Therapies": "Tamoxifen",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:10786679"
  },
  {
    "": 114,
    "Gene name": "ESR1",
    "Genomic Position": "6:152011631-152424409(+)",
    "CDS Mutation": "Overexpression",
    "AA Mutation": "Overexpression",
    "Disease": "Breast Cancer",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26434753"
  },
  {
    "": 115,
    "Gene name": "ESR1",
    "Genomic Position": "6:152011631-152424409(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26434753"
  },
  {
    "": 116,
    "Gene name": "ESR1",
    "Genomic Position": "6:152011631-152424409(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / ER-positive carcinoma",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26434753"
  },
  {
    "": 117,
    "Gene name": "ESR1",
    "Genomic Position": "6:152011631-152424409(+)",
    "CDS Mutation": "c.*485A>C",
    "AA Mutation": "p.?",
    "Disease": "ductolobular_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26434753"
  },
  {
    "": 118,
    "Gene name": "ESR1",
    "Genomic Position": "6:152011631-152424409(+)",
    "CDS Mutation": "c.827A>C",
    "AA Mutation": "p.Y276S",
    "Disease": "ductolobular_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26434753"
  },
  {
    "": 119,
    "Gene name": "ESR1",
    "Genomic Position": "6:152011631-152424409(+)",
    "CDS Mutation": "c.851-26478A>C",
    "AA Mutation": "p.?",
    "Disease": "ductolobular_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26434753"
  },
  {
    "": 120,
    "Gene name": "ESR1",
    "Genomic Position": "6:152011631-152424409(+)",
    "CDS Mutation": "c.1610A>C",
    "AA Mutation": "p.Y537S",
    "Disease": "ductolobular_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26434753"
  },
  {
    "": 121,
    "Gene name": "ESR1",
    "Genomic Position": "6:152011631-152424409(+)",
    "CDS Mutation": "c.851-26478A>C",
    "AA Mutation": "p.?",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26434753"
  },
  {
    "": 122,
    "Gene name": "ESR1",
    "Genomic Position": "6:152011631-152424409(+)",
    "CDS Mutation": "c.1610A>C",
    "AA Mutation": "p.Y537S",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26434753"
  },
  {
    "": 123,
    "Gene name": "ESR1",
    "Genomic Position": "6:152011631-152424409(+)",
    "CDS Mutation": "c.*485A>C",
    "AA Mutation": "p.?",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26434753"
  },
  {
    "": 124,
    "Gene name": "ESR1",
    "Genomic Position": "6:152011631-152424409(+)",
    "CDS Mutation": "c.827A>C",
    "AA Mutation": "p.Y276S",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26434753"
  },
  {
    "": 125,
    "Gene name": "ESR1",
    "Genomic Position": "6:152011631-152424409(+)",
    "CDS Mutation": "c.*485A>C",
    "AA Mutation": "p.?",
    "Disease": "lobular_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26434753"
  },
  {
    "": 126,
    "Gene name": "ESR1",
    "Genomic Position": "6:152011631-152424409(+)",
    "CDS Mutation": "c.827A>C",
    "AA Mutation": "p.Y276S",
    "Disease": "lobular_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26434753"
  },
  {
    "": 127,
    "Gene name": "ESR1",
    "Genomic Position": "6:152011631-152424409(+)",
    "CDS Mutation": "c.1610A>C",
    "AA Mutation": "p.Y537S",
    "Disease": "lobular_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26434753"
  },
  {
    "": 128,
    "Gene name": "ESR1",
    "Genomic Position": "6:152011631-152424409(+)",
    "CDS Mutation": "c.851-26478A>C",
    "AA Mutation": "p.?",
    "Disease": "lobular_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26434753"
  },
  {
    "": 129,
    "Gene name": "ESR1",
    "Genomic Position": "6:152011631-152424409(+)",
    "CDS Mutation": "c.?",
    "AA Mutation": "p.Y537C",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26434753"
  },
  {
    "": 130,
    "Gene name": "ESR1",
    "Genomic Position": "6:152011631-152424409(+)",
    "CDS Mutation": "c.?",
    "AA Mutation": "p.Y537S",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26434753"
  },
  {
    "": 131,
    "Gene name": "ESR1",
    "Genomic Position": "6:152011631-152424409(+)",
    "CDS Mutation": "c.1607T>A",
    "AA Mutation": "p.L536H",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26434753"
  },
  {
    "": 132,
    "Gene name": "ESR1",
    "Genomic Position": "6:152011631-152424409(+)",
    "CDS Mutation": "c.1613A>G",
    "AA Mutation": "p.D538G",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26434753"
  },
  {
    "": 133,
    "Gene name": "ESR1",
    "Genomic Position": "6:152011631-152424409(+)",
    "CDS Mutation": "c.830A>G",
    "AA Mutation": "p.D277G",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26434753"
  },
  {
    "": 134,
    "Gene name": "ESR1",
    "Genomic Position": "6:152011631-152424409(+)",
    "CDS Mutation": "c.824T>A",
    "AA Mutation": "p.L275H",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26434753"
  },
  {
    "": 135,
    "Gene name": "ESR1",
    "Genomic Position": "6:152011631-152424409(+)",
    "CDS Mutation": "c.*488A>G",
    "AA Mutation": "p.?",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26434753"
  },
  {
    "": 136,
    "Gene name": "ESR1",
    "Genomic Position": "6:152011631-152424409(+)",
    "CDS Mutation": "c.851-26475A>G",
    "AA Mutation": "p.?",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26434753"
  },
  {
    "": 137,
    "Gene name": "ESR1",
    "Genomic Position": "6:152011631-152424409(+)",
    "CDS Mutation": "c.*482T>A",
    "AA Mutation": "p.?",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26434753"
  },
  {
    "": 138,
    "Gene name": "ESR1",
    "Genomic Position": "6:152011631-152424409(+)",
    "CDS Mutation": "c.851-26481T>A",
    "AA Mutation": "p.?",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26434753"
  },
  {
    "": 139,
    "Gene name": "ESR1",
    "Genomic Position": "6:152011631-152424409(+)",
    "CDS Mutation": "c.851-26478A>G",
    "AA Mutation": "p.?",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26434753"
  },
  {
    "": 140,
    "Gene name": "ESR1",
    "Genomic Position": "6:152011631-152424409(+)",
    "CDS Mutation": "c.827A>G",
    "AA Mutation": "p.Y276C",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26434753"
  },
  {
    "": 141,
    "Gene name": "ESR1",
    "Genomic Position": "6:152011631-152424409(+)",
    "CDS Mutation": "c.1610A>G",
    "AA Mutation": "p.Y537C",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26434753"
  },
  {
    "": 142,
    "Gene name": "ESR1",
    "Genomic Position": "6:152011631-152424409(+)",
    "CDS Mutation": "c.*485A>G",
    "AA Mutation": "p.?",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26434753"
  },
  {
    "": 143,
    "Gene name": "ESR1",
    "Genomic Position": "6:152011631-152424409(+)",
    "CDS Mutation": "c.1609T>A",
    "AA Mutation": "p.Y537N",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26434753"
  },
  {
    "": 144,
    "Gene name": "ESR1",
    "Genomic Position": "6:152011631-152424409(+)",
    "CDS Mutation": "c.851-26479T>A",
    "AA Mutation": "p.?",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26434753"
  },
  {
    "": 145,
    "Gene name": "ESR1",
    "Genomic Position": "6:152011631-152424409(+)",
    "CDS Mutation": "c.826T>A",
    "AA Mutation": "p.Y276N",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26434753"
  },
  {
    "": 146,
    "Gene name": "ESR1",
    "Genomic Position": "6:152011631-152424409(+)",
    "CDS Mutation": "c.*484T>A",
    "AA Mutation": "p.?",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26434753"
  },
  {
    "": 147,
    "Gene name": "ESR1",
    "Genomic Position": "6:152011631-152424409(+)",
    "CDS Mutation": "c.1610A>C",
    "AA Mutation": "p.Y537S",
    "Disease": "ductal_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26434753"
  },
  {
    "": 148,
    "Gene name": "ESR1",
    "Genomic Position": "6:152011631-152424409(+)",
    "CDS Mutation": "c.827A>C",
    "AA Mutation": "p.Y276S",
    "Disease": "ductal_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26434753"
  },
  {
    "": 149,
    "Gene name": "ESR1",
    "Genomic Position": "6:152011631-152424409(+)",
    "CDS Mutation": "c.*485A>C",
    "AA Mutation": "p.?",
    "Disease": "ductal_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26434753"
  },
  {
    "": 150,
    "Gene name": "ESR1",
    "Genomic Position": "6:152011631-152424409(+)",
    "CDS Mutation": "c.851-26478A>C",
    "AA Mutation": "p.?",
    "Disease": "ductal_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26434753"
  },
  {
    "": 151,
    "Gene name": "ESR1",
    "Genomic Position": "6:152011631-152424409(+)",
    "CDS Mutation": "c.851-26475A>G",
    "AA Mutation": "p.?",
    "Disease": "ductal_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26434753"
  },
  {
    "": 152,
    "Gene name": "ESR1",
    "Genomic Position": "6:152011631-152424409(+)",
    "CDS Mutation": "c.1613A>G",
    "AA Mutation": "p.D538G",
    "Disease": "ductal_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26434753"
  },
  {
    "": 153,
    "Gene name": "ESR1",
    "Genomic Position": "6:152011631-152424409(+)",
    "CDS Mutation": "c.830A>G",
    "AA Mutation": "p.D277G",
    "Disease": "ductal_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26434753"
  },
  {
    "": 154,
    "Gene name": "ESR1",
    "Genomic Position": "6:152011631-152424409(+)",
    "CDS Mutation": "c.*488A>G",
    "AA Mutation": "p.?",
    "Disease": "ductal_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26434753"
  },
  {
    "": 155,
    "Gene name": "ESR1",
    "Genomic Position": "6:152011631-152424409(+)",
    "CDS Mutation": "c.?",
    "AA Mutation": "p.D538G",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26434753"
  },
  {
    "": 156,
    "Gene name": "ESR1",
    "Genomic Position": "6:152011631-152424409(+)",
    "CDS Mutation": "c.851-26481",
    "AA Mutation": "p.?",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26434753"
  },
  {
    "": 157,
    "Gene name": "ESR1",
    "Genomic Position": "6:152011631-152424409(+)",
    "CDS Mutation": "c.1607",
    "AA Mutation": "p.L536Q",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26434753"
  },
  {
    "": 158,
    "Gene name": "ESR1",
    "Genomic Position": "6:152011631-152424409(+)",
    "CDS Mutation": "c.*482",
    "AA Mutation": "p.?",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26434753"
  },
  {
    "": 159,
    "Gene name": "ESR1",
    "Genomic Position": "6:152011631-152424409(+)",
    "CDS Mutation": "c.824",
    "AA Mutation": "p.L275Q",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26434753"
  },
  {
    "": 160,
    "Gene name": "ESR1",
    "Genomic Position": "6:152011631-152424409(+)",
    "CDS Mutation": "(AA)/",
    "AA Mutation": "p.L536",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26434753"
  },
  {
    "": 161,
    "Gene name": "ESR1",
    "Genomic Position": "6:152011631-152424409(+)",
    "CDS Mutation": "c.?",
    "AA Mutation": "p.Y537N",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26434753"
  },
  {
    "": 162,
    "Gene name": "ESR1",
    "Genomic Position": "6:152011631-152424409(+)",
    "CDS Mutation": "c.*111-49294G>C",
    "AA Mutation": "p.?",
    "Disease": "ductal_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26434753"
  },
  {
    "": 163,
    "Gene name": "ESR1",
    "Genomic Position": "6:152011631-152424409(+)",
    "CDS Mutation": "c.1138G>C",
    "AA Mutation": "p.E380Q",
    "Disease": "ductal_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26434753"
  },
  {
    "": 164,
    "Gene name": "ESR1",
    "Genomic Position": "6:152011631-152424409(+)",
    "CDS Mutation": "c.42+67448G>C",
    "AA Mutation": "p.?",
    "Disease": "ductal_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26434753"
  },
  {
    "": 165,
    "Gene name": "ESR1",
    "Genomic Position": "6:152011631-152424409(+)",
    "CDS Mutation": "c.619G>C",
    "AA Mutation": "p.E207Q",
    "Disease": "ductal_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26434753"
  },
  {
    "": 166,
    "Gene name": "ESR1",
    "Genomic Position": "6:152011631-152424409(+)",
    "CDS Mutation": "c.453-49294G>C",
    "AA Mutation": "p.?",
    "Disease": "ductal_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26434753"
  },
  {
    "": 167,
    "Gene name": "ESR1",
    "Genomic Position": "6:152011631-152424409(+)",
    "CDS Mutation": "c.?",
    "AA Mutation": "p.Y537S",
    "Disease": "ductal_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26434753"
  },
  {
    "": 168,
    "Gene name": "PTEN",
    "Genomic Position": "10:89622870-89731687(+)",
    "CDS Mutation": "Loss",
    "AA Mutation": "Loss",
    "Disease": "Breast Cancer",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Everolimus,Fulvestrant",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:27445490"
  },
  {
    "": 169,
    "Gene name": "PTEN",
    "Genomic Position": "10:89622870-89731687(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Everolimus,Fulvestrant",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:27445490"
  },
  {
    "": 170,
    "Gene name": "PTEN",
    "Genomic Position": "10:89622870-89731687(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / basal (triple-negative) carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Everolimus,Fulvestrant",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:27445490"
  },
  {
    "": 171,
    "Gene name": "PTEN",
    "Genomic Position": "10:89622870-89731687(+)",
    "CDS Mutation": "Loss",
    "AA Mutation": "Loss",
    "Disease": "Her2-receptor Positive Breast Cancer",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Everolimus,Fulvestrant",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:27445490"
  },
  {
    "": 172,
    "Gene name": "PTEN",
    "Genomic Position": "10:89622870-89731687(+)",
    "CDS Mutation": "Expression",
    "AA Mutation": "Expression",
    "Disease": "Breast Cancer",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Everolimus,Fulvestrant",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:27445490"
  },
  {
    "": 173,
    "Gene name": "PTEN",
    "Genomic Position": "10:89622870-89731687(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Everolimus,Fulvestrant",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:27445490"
  },
  {
    "": 174,
    "Gene name": "PTEN",
    "Genomic Position": "10:89622870-89731687(+)",
    "CDS Mutation": "Loss",
    "AA Mutation": "Loss",
    "Disease": "Her2-receptor Positive Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Everolimus,Fulvestrant",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:27445490"
  },
  {
    "": 175,
    "Gene name": "PTEN",
    "Genomic Position": "10:89622870-89731687(+)",
    "CDS Mutation": "Expression",
    "AA Mutation": "Expression",
    "Disease": "Her2-receptor Positive Breast Cancer",
    "therapy_rank": 4,
    "Response to Drug": "Resistance",
    "Therapies": "Everolimus,Fulvestrant",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:27445490"
  },
  {
    "": 176,
    "Gene name": "SI",
    "Genomic Position": "3:164696686-164796283(-)",
    "CDS Mutation": "EXPRESSION",
    "AA Mutation": "EXPRESSION",
    "Disease": "Breast Cancer",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Epirubicin",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:22431701"
  },
  {
    "": 177,
    "Gene name": "SI",
    "Genomic Position": "3:164696686-164796283(-)",
    "CDS Mutation": "EXPRESSION",
    "AA Mutation": "EXPRESSION",
    "Disease": "Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Epirubicin",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:22431701"
  },
  {
    "": 178,
    "Gene name": "SI",
    "Genomic Position": "3:164696686-164796283(-)",
    "CDS Mutation": "EXPRESSION",
    "AA Mutation": "EXPRESSION",
    "Disease": "Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Resistance",
    "Therapies": "Epirubicin",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:22431701"
  },
  {
    "": 179,
    "Gene name": "TUB",
    "Genomic Position": "11:8060180-8127659(+)",
    "CDS Mutation": "EXPRESSION",
    "AA Mutation": "EXPRESSION",
    "Disease": "Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Taxane Compound",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:23218766"
  },
  {
    "": 180,
    "Gene name": "NTRK3",
    "Genomic Position": "15:88420022-88799661(-)",
    "CDS Mutation": "ETV6::NTRK3",
    "AA Mutation": "p.ETV6::NTRK3",
    "Disease": "Breast Secretory Carcinoma",
    "therapy_rank": 4,
    "Response to Drug": "Sensitivity",
    "Therapies": "Larotrectinib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:29623306"
  },
  {
    "": 181,
    "Gene name": "BRCA2",
    "Genomic Position": "13:32889617-32973805(+)",
    "CDS Mutation": "unspecified_and_ERBB2_unspecified",
    "AA Mutation": "unspecified_and_ERBB2_unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Capecitabine + Platinum-based chemotherapy",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT04335669"
  },
  {
    "": 182,
    "Gene name": "BRCA2",
    "Genomic Position": "13:32889617-32973805(+)",
    "CDS Mutation": "Mutation",
    "AA Mutation": "Mutation",
    "Disease": "Triple-receptor Negative Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Capecitabine + Platinum-based chemotherapy",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT04335669"
  },
  {
    "": 183,
    "Gene name": "BRCA2",
    "Genomic Position": "13:32889617-32973805(+)",
    "CDS Mutation": "Loss-of-function",
    "AA Mutation": "Loss-of-function",
    "Disease": "Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Capecitabine + Platinum-based chemotherapy",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT04335669"
  },
  {
    "": 184,
    "Gene name": "BRCA2",
    "Genomic Position": "13:32889617-32973805(+)",
    "CDS Mutation": "Loss-of-function",
    "AA Mutation": "Loss-of-function",
    "Disease": "Her2-receptor Negative Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Capecitabine + Platinum-based chemotherapy",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT04335669"
  },
  {
    "": 185,
    "Gene name": "BRCA2",
    "Genomic Position": "13:32889617-32973805(+)",
    "CDS Mutation": "Mutation",
    "AA Mutation": "Mutation",
    "Disease": "Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Capecitabine + Platinum-based chemotherapy",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT04335669"
  },
  {
    "": 186,
    "Gene name": "BRCA2",
    "Genomic Position": "13:32889617-32973805(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Capecitabine + Platinum-based chemotherapy",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT04335669"
  },
  {
    "": 187,
    "Gene name": "FGFR2",
    "Genomic Position": "10:123239371-123357917(-)",
    "CDS Mutation": "Amplification",
    "AA Mutation": "Amplification",
    "Disease": "Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:32723837"
  },
  {
    "": 188,
    "Gene name": "FGFR2",
    "Genomic Position": "10:123239371-123357917(-)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:32723837"
  },
  {
    "": 189,
    "Gene name": "FGFR2",
    "Genomic Position": "10:123239371-123357917(-)",
    "CDS Mutation": "c.1380T>A",
    "AA Mutation": "p.N460K",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:32723837"
  },
  {
    "": 190,
    "Gene name": "FGFR2",
    "Genomic Position": "10:123239371-123357917(-)",
    "CDS Mutation": "c.963T>A",
    "AA Mutation": "p.N321K",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:32723837"
  },
  {
    "": 191,
    "Gene name": "FGFR2",
    "Genomic Position": "10:123239371-123357917(-)",
    "CDS Mutation": "c.1296T>A",
    "AA Mutation": "p.N432K",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:32723837"
  },
  {
    "": 192,
    "Gene name": "FGFR2",
    "Genomic Position": "10:123239371-123357917(-)",
    "CDS Mutation": "c.1299T>A",
    "AA Mutation": "p.N433K",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:32723837"
  },
  {
    "": 193,
    "Gene name": "FGFR2",
    "Genomic Position": "10:123239371-123357917(-)",
    "CDS Mutation": "c.1647T>A",
    "AA Mutation": "p.N549K",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:32723837"
  },
  {
    "": 194,
    "Gene name": "FGFR2",
    "Genomic Position": "10:123239371-123357917(-)",
    "CDS Mutation": "c.1641T>A",
    "AA Mutation": "p.N547K",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:32723837"
  },
  {
    "": 195,
    "Gene name": "FGFR2",
    "Genomic Position": "10:123239371-123357917(-)",
    "CDS Mutation": "c.1383T>A",
    "AA Mutation": "p.N461K",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:32723837"
  },
  {
    "": 196,
    "Gene name": "FGFR2",
    "Genomic Position": "10:123239371-123357917(-)",
    "CDS Mutation": "c.1311T>A",
    "AA Mutation": "p.N437K",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:32723837"
  },
  {
    "": 197,
    "Gene name": "FGFR2",
    "Genomic Position": "10:123239371-123357917(-)",
    "CDS Mutation": "c.1650T>A",
    "AA Mutation": "p.N550K",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:32723837"
  },
  {
    "": 198,
    "Gene name": "FGFR2",
    "Genomic Position": "10:123239371-123357917(-)",
    "CDS Mutation": "c.1305T>A",
    "AA Mutation": "p.N435K",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:32723837"
  },
  {
    "": 199,
    "Gene name": "FGFR2",
    "Genomic Position": "10:123239371-123357917(-)",
    "CDS Mutation": "c.839T>A",
    "AA Mutation": "p.V280D",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:32723837"
  },
  {
    "": 200,
    "Gene name": "FGFR2",
    "Genomic Position": "10:123239371-123357917(-)",
    "CDS Mutation": "c.842T>A",
    "AA Mutation": "p.V281D",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:32723837"
  },
  {
    "": 201,
    "Gene name": "FGFR2",
    "Genomic Position": "10:123239371-123357917(-)",
    "CDS Mutation": "c.917T>A",
    "AA Mutation": "p.V306D",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:32723837"
  },
  {
    "": 202,
    "Gene name": "FGFR2",
    "Genomic Position": "10:123239371-123357917(-)",
    "CDS Mutation": "c.848T>A",
    "AA Mutation": "p.V283D",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:32723837"
  },
  {
    "": 203,
    "Gene name": "FGFR2",
    "Genomic Position": "10:123239371-123357917(-)",
    "CDS Mutation": "c.500T>A",
    "AA Mutation": "p.V167D",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:32723837"
  },
  {
    "": 204,
    "Gene name": "FGFR2",
    "Genomic Position": "10:123239371-123357917(-)",
    "CDS Mutation": "c.939+4759T>A",
    "AA Mutation": "p.?",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:32723837"
  },
  {
    "": 205,
    "Gene name": "FGFR2",
    "Genomic Position": "10:123239371-123357917(-)",
    "CDS Mutation": "c.1187T>A",
    "AA Mutation": "p.V396D",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:32723837"
  },
  {
    "": 206,
    "Gene name": "FGFR2",
    "Genomic Position": "10:123239371-123357917(-)",
    "CDS Mutation": "c.920T>A",
    "AA Mutation": "p.V307D",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:32723837"
  },
  {
    "": 207,
    "Gene name": "FGFR2",
    "Genomic Position": "10:123239371-123357917(-)",
    "CDS Mutation": "c.1184T>A",
    "AA Mutation": "p.V395D",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:32723837"
  },
  {
    "": 208,
    "Gene name": "FGFR2",
    "Genomic Position": "10:123239371-123357917(-)",
    "CDS Mutation": "c.1190T>A",
    "AA Mutation": "p.V397D",
    "Disease": "ER-positive_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:32723837"
  },
  {
    "": 209,
    "Gene name": "FGFR2",
    "Genomic Position": "10:123239371-123357917(-)",
    "CDS Mutation": "c.1296T>A",
    "AA Mutation": "p.N432K",
    "Disease": "ductolobular_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:32723837"
  },
  {
    "": 210,
    "Gene name": "FGFR2",
    "Genomic Position": "10:123239371-123357917(-)",
    "CDS Mutation": "c.1380T>A",
    "AA Mutation": "p.N460K",
    "Disease": "ductolobular_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:32723837"
  },
  {
    "": 211,
    "Gene name": "FGFR2",
    "Genomic Position": "10:123239371-123357917(-)",
    "CDS Mutation": "c.1299T>A",
    "AA Mutation": "p.N433K",
    "Disease": "ductolobular_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:32723837"
  },
  {
    "": 212,
    "Gene name": "FGFR2",
    "Genomic Position": "10:123239371-123357917(-)",
    "CDS Mutation": "c.1647T>A",
    "AA Mutation": "p.N549K",
    "Disease": "ductolobular_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:32723837"
  },
  {
    "": 213,
    "Gene name": "FGFR2",
    "Genomic Position": "10:123239371-123357917(-)",
    "CDS Mutation": "c.1650T>A",
    "AA Mutation": "p.N550K",
    "Disease": "ductolobular_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:32723837"
  },
  {
    "": 214,
    "Gene name": "FGFR2",
    "Genomic Position": "10:123239371-123357917(-)",
    "CDS Mutation": "c.1305T>A",
    "AA Mutation": "p.N435K",
    "Disease": "ductolobular_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:32723837"
  },
  {
    "": 215,
    "Gene name": "FGFR2",
    "Genomic Position": "10:123239371-123357917(-)",
    "CDS Mutation": "c.1641T>A",
    "AA Mutation": "p.N547K",
    "Disease": "ductolobular_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:32723837"
  },
  {
    "": 216,
    "Gene name": "FGFR2",
    "Genomic Position": "10:123239371-123357917(-)",
    "CDS Mutation": "c.1311T>A",
    "AA Mutation": "p.N437K",
    "Disease": "ductolobular_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:32723837"
  },
  {
    "": 217,
    "Gene name": "FGFR2",
    "Genomic Position": "10:123239371-123357917(-)",
    "CDS Mutation": "c.963T>A",
    "AA Mutation": "p.N321K",
    "Disease": "ductolobular_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:32723837"
  },
  {
    "": 218,
    "Gene name": "FGFR2",
    "Genomic Position": "10:123239371-123357917(-)",
    "CDS Mutation": "c.1383T>A",
    "AA Mutation": "p.N461K",
    "Disease": "ductolobular_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:32723837"
  },
  {
    "": 219,
    "Gene name": "FGFR2",
    "Genomic Position": "10:123239371-123357917(-)",
    "CDS Mutation": "c.1611G>A",
    "AA Mutation": "p.M537I",
    "Disease": "ductolobular_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:32723837"
  },
  {
    "": 220,
    "Gene name": "FGFR2",
    "Genomic Position": "10:123239371-123357917(-)",
    "CDS Mutation": "c.1344G>A",
    "AA Mutation": "p.M448I",
    "Disease": "ductolobular_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:32723837"
  },
  {
    "": 221,
    "Gene name": "FGFR2",
    "Genomic Position": "10:123239371-123357917(-)",
    "CDS Mutation": "c.1605G>A",
    "AA Mutation": "p.M535I",
    "Disease": "ductolobular_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:32723837"
  },
  {
    "": 222,
    "Gene name": "FGFR2",
    "Genomic Position": "10:123239371-123357917(-)",
    "CDS Mutation": "c.1614G>A",
    "AA Mutation": "p.M538I",
    "Disease": "ductolobular_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:32723837"
  },
  {
    "": 223,
    "Gene name": "FGFR2",
    "Genomic Position": "10:123239371-123357917(-)",
    "CDS Mutation": "c.1275G>A",
    "AA Mutation": "p.M425I",
    "Disease": "ductolobular_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:32723837"
  },
  {
    "": 224,
    "Gene name": "FGFR2",
    "Genomic Position": "10:123239371-123357917(-)",
    "CDS Mutation": "c.1269G>A",
    "AA Mutation": "p.M423I",
    "Disease": "ductolobular_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:32723837"
  },
  {
    "": 225,
    "Gene name": "FGFR2",
    "Genomic Position": "10:123239371-123357917(-)",
    "CDS Mutation": "c.1260G>A",
    "AA Mutation": "p.M420I",
    "Disease": "ductolobular_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:32723837"
  },
  {
    "": 226,
    "Gene name": "FGFR2",
    "Genomic Position": "10:123239371-123357917(-)",
    "CDS Mutation": "c.1347G>A",
    "AA Mutation": "p.M449I",
    "Disease": "ductolobular_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:32723837"
  },
  {
    "": 227,
    "Gene name": "FGFR2",
    "Genomic Position": "10:123239371-123357917(-)",
    "CDS Mutation": "c.1263G>A",
    "AA Mutation": "p.M421I",
    "Disease": "ductolobular_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:32723837"
  },
  {
    "": 228,
    "Gene name": "FGFR2",
    "Genomic Position": "10:123239371-123357917(-)",
    "CDS Mutation": "c.927G>A",
    "AA Mutation": "p.M309I",
    "Disease": "ductolobular_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Endocrine therapy",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:32723837"
  },
  {
    "": 229,
    "Gene name": "MMP2",
    "Genomic Position": "16:55512883-55540603(+)",
    "CDS Mutation": "SERUM_LEVELS",
    "AA Mutation": "SERUM_LEVELS",
    "Disease": "Inflammatory Breast Carcinoma",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Bevacizumab",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26921265"
  },
  {
    "": 230,
    "Gene name": "TOP2A",
    "Genomic Position": "17:38544768-38574202(-)",
    "CDS Mutation": "EXPRESSION",
    "AA Mutation": "EXPRESSION",
    "Disease": "Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Doxorubicin",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:15486187"
  },
  {
    "": 231,
    "Gene name": "F2",
    "Genomic Position": "11:46740730-46761056(+)",
    "CDS Mutation": "K159fs",
    "AA Mutation": "p.K159fs",
    "Disease": "Breast Cancer",
    "therapy_rank": 4,
    "Response to Drug": "Sensitivity",
    "Therapies": "Temsirolimus",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:25878190"
  },
  {
    "": 232,
    "Gene name": "CDK6",
    "Genomic Position": "7:92234235-92463231(-)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Fulvestrant",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:27252418"
  },
  {
    "": 233,
    "Gene name": "CDK6",
    "Genomic Position": "7:92234235-92463231(-)",
    "CDS Mutation": "Overexpression",
    "AA Mutation": "Overexpression",
    "Disease": "Estrogen-receptor Positive Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Resistance",
    "Therapies": "Fulvestrant",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:27252418"
  },
  {
    "": 234,
    "Gene name": "AKT1",
    "Genomic Position": "14:105235686-105260461(-)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Capivasertib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26351323"
  },
  {
    "": 235,
    "Gene name": "AKT1",
    "Genomic Position": "14:105235686-105260461(-)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Capivasertib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26351323"
  },
  {
    "": 236,
    "Gene name": "AKT1",
    "Genomic Position": "14:105235686-105260461(-)",
    "CDS Mutation": "unspecified_or_PIK3CA_unspecified_or_PTEN_unspecified",
    "AA Mutation": "unspecified_or_PIK3CA_unspecified_or_PTEN_unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Capivasertib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26351323"
  },
  {
    "": 237,
    "Gene name": "AKT1",
    "Genomic Position": "14:105235686-105260461(-)",
    "CDS Mutation": "unspecified_or_PIK3CA_unspecified_or_PTEN_unspecified",
    "AA Mutation": "unspecified_or_PIK3CA_unspecified_or_PTEN_unspecified",
    "Disease": "breast / carcinoma / basal (triple-negative) carcinoma",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Capivasertib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26351323"
  },
  {
    "": 238,
    "Gene name": "AKT1",
    "Genomic Position": "14:105235686-105260461(-)",
    "CDS Mutation": "c.49G>A",
    "AA Mutation": "p.E17K",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Capivasertib",
    "Description": "",
    "rs value": 121434592,
    "pmid": "PubMed:26351323"
  },
  {
    "": 239,
    "Gene name": "AKT1",
    "Genomic Position": "14:105235686-105260461(-)",
    "CDS Mutation": "unspecified_or_ATM_unspecified_or_ATR_unspecified_or_BARD1_unspecified_or_BRCA1_unspecified_or_BRCA2_unspecified_or_BRIP1_unspecified_or_CHEK2_unspecified_or_FANCA_unspecified_or_FANCC_undefined_or_FANCD2_undefined_or_FANCE_undefined_or_FANCF_undefined_or_FANCG_undefined_or_FANCL_undefined_or_MRE11_unspecified_or_NBN_unspecified_or_PALB2_unspecified_or_PIK3CA_unspecified_or_PTEN_unspecified_or_RAD50_unspecified_or_RAD51C_unspecified_or_RAD51D_unspecified",
    "AA Mutation": "unspecified_or_ATM_unspecified_or_ATR_unspecified_or_BARD1_unspecified_or_BRCA1_unspecified_or_BRCA2_unspecified_or_BRIP1_unspecified_or_CHEK2_unspecified_or_FANCA_unspecified_or_FANCC_undefined_or_FANCD2_undefined_or_FANCE_undefined_or_FANCF_undefined_or_FANCG_undefined_or_FANCL_undefined_or_MRE11_unspecified_or_NBN_unspecified_or_PALB2_unspecified_or_PIK3CA_unspecified_or_PTEN_unspecified_or_RAD50_unspecified_or_RAD51C_unspecified_or_RAD51D_unspecified",
    "Disease": "breast / carcinoma / basal (triple-negative) carcinoma",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Capivasertib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26351323"
  },
  {
    "": 240,
    "Gene name": "AKT1",
    "Genomic Position": "14:105235686-105260461(-)",
    "CDS Mutation": "c.49G>A",
    "AA Mutation": "p.E17K",
    "Disease": "Breast Cancer",
    "therapy_rank": 4,
    "Response to Drug": "Sensitivity",
    "Therapies": "Capivasertib",
    "Description": "",
    "rs value": 121434592,
    "pmid": "PubMed:26351323"
  },
  {
    "": 241,
    "Gene name": "F3",
    "Genomic Position": "1:94994781-95007356(-)",
    "CDS Mutation": "EXPRESSION",
    "AA Mutation": "EXPRESSION",
    "Disease": "Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Dovitinib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:23658459"
  },
  {
    "": 242,
    "Gene name": "F3",
    "Genomic Position": "1:94994781-95007356(-)",
    "CDS Mutation": "Amplification",
    "AA Mutation": "Amplification",
    "Disease": "Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Dovitinib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:23658459"
  },
  {
    "": 243,
    "Gene name": "LAT",
    "Genomic Position": "16:28996147-29002104(+)",
    "CDS Mutation": "PHOSPHORYLATION",
    "AA Mutation": "p.PHOSPHORYLATION",
    "Disease": "Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Resistance",
    "Therapies": "Alpelisib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:25002028"
  },
  {
    "": 244,
    "Gene name": "MMP9",
    "Genomic Position": "20:44637547-44645200(+)",
    "CDS Mutation": "SERUM_LEVELS",
    "AA Mutation": "SERUM_LEVELS",
    "Disease": "Inflammatory Breast Carcinoma",
    "therapy_rank": 3,
    "Response to Drug": "Resistance",
    "Therapies": "Bevacizumab",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26921265"
  },
  {
    "": 245,
    "Gene name": "ETV6",
    "Genomic Position": "12:11802788-12048336(+)",
    "CDS Mutation": "ETV6::NTRK3",
    "AA Mutation": "p.ETV6::NTRK3",
    "Disease": "Breast Secretory Carcinoma",
    "therapy_rank": 4,
    "Response to Drug": "Sensitivity",
    "Therapies": "Larotrectinib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:29623306"
  },
  {
    "": 246,
    "Gene name": "RSF1",
    "Genomic Position": "11:77371041-77532063(-)",
    "CDS Mutation": "Amplification",
    "AA Mutation": "Amplification",
    "Disease": "Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Resistance",
    "Therapies": "Tamoxifen",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:24367492"
  },
  {
    "": 247,
    "Gene name": "C5",
    "Genomic Position": "9:123714616-123812554(-)",
    "CDS Mutation": "Overexpression",
    "AA Mutation": "Overexpression",
    "Disease": "Her2-receptor Positive Breast Cancer",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Trastuzumab",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:23204226"
  },
  {
    "": 248,
    "Gene name": "AGR2",
    "Genomic Position": "7:16831435-16844704(-)",
    "CDS Mutation": "EXPRESSION",
    "AA Mutation": "EXPRESSION",
    "Disease": "Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Resistance",
    "Therapies": "Tamoxifen",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:24167368"
  },
  {
    "": 249,
    "Gene name": "TF",
    "Genomic Position": "3:133464800-133497850(+)",
    "CDS Mutation": "EXPRESSION",
    "AA Mutation": "EXPRESSION",
    "Disease": "Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Aminoglutethimide,Tamoxifen",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:25900183"
  },
  {
    "": 250,
    "Gene name": "CA2",
    "Genomic Position": "8:86376081-86393722(+)",
    "CDS Mutation": "Mutation",
    "AA Mutation": "Mutation",
    "Disease": "Triple-receptor Negative Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Olaparib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:28792849"
  },
  {
    "": 251,
    "Gene name": "CA2",
    "Genomic Position": "8:86376081-86393722(+)",
    "CDS Mutation": "Loss-of-function",
    "AA Mutation": "Loss-of-function",
    "Disease": "Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Olaparib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:28792849"
  },
  {
    "": 252,
    "Gene name": "CA2",
    "Genomic Position": "8:86376081-86393722(+)",
    "CDS Mutation": "Loss-of-function",
    "AA Mutation": "Loss-of-function",
    "Disease": "Her2-receptor Negative Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Olaparib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:28792849"
  },
  {
    "": 253,
    "Gene name": "CA2",
    "Genomic Position": "8:86376081-86393722(+)",
    "CDS Mutation": "Mutation",
    "AA Mutation": "Mutation",
    "Disease": "Breast Cancer",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Olaparib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:28792849"
  },
  {
    "": 254,
    "Gene name": "CDK4",
    "Genomic Position": "12:58141510-58146304(-)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Erdafitinib + Fulvestrant + Palbociclib",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT03238196"
  },
  {
    "": 255,
    "Gene name": "BARD1",
    "Genomic Position": "2:215590370-215674428(-)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Talazoparib",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT04892693"
  },
  {
    "": 256,
    "Gene name": "AR",
    "Genomic Position": "X:66764465-66950461(+)",
    "CDS Mutation": "unspecified_and_ERBB2_unspecified",
    "AA Mutation": "unspecified_and_ERBB2_unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Aromatase inhibitors + Bicalutamide",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:NCT02910050"
  },
  {
    "": 257,
    "Gene name": "AR",
    "Genomic Position": "X:66764465-66950461(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / basal (triple-negative) carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Aromatase inhibitors + Bicalutamide",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:NCT02910050"
  },
  {
    "": 258,
    "Gene name": "AR",
    "Genomic Position": "X:66764465-66950461(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Aromatase inhibitors + Bicalutamide",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:NCT02910050"
  },
  {
    "": 259,
    "Gene name": "AR",
    "Genomic Position": "X:66764465-66950461(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / basal (triple-negative) carcinoma",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Aromatase inhibitors + Bicalutamide",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:NCT02910050"
  },
  {
    "": 260,
    "Gene name": "AR",
    "Genomic Position": "X:66764465-66950461(+)",
    "CDS Mutation": "unspecified_or_PTEN_unspecified",
    "AA Mutation": "unspecified_or_PTEN_unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Aromatase inhibitors + Bicalutamide",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:NCT02910050"
  },
  {
    "": 261,
    "Gene name": "AR",
    "Genomic Position": "X:66764465-66950461(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Aromatase inhibitors + Bicalutamide",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:NCT02910050"
  },
  {
    "": 262,
    "Gene name": "AR",
    "Genomic Position": "X:66764465-66950461(+)",
    "CDS Mutation": "unspecified_and_ERBB2_unspecified",
    "AA Mutation": "unspecified_and_ERBB2_unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Aromatase inhibitors + Bicalutamide",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:NCT02910050"
  },
  {
    "": 263,
    "Gene name": "AR",
    "Genomic Position": "X:66764465-66950461(+)",
    "CDS Mutation": "unspecified_and_ESR1_unspecified",
    "AA Mutation": "unspecified_and_ESR1_unspecified",
    "Disease": "breast / carcinoma / ER-positive carcinoma",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Aromatase inhibitors + Bicalutamide",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:NCT02910050"
  },
  {
    "": 264,
    "Gene name": "EGFR",
    "Genomic Position": "7:55086794-55279321(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Gefitinib",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT01732276"
  },
  {
    "": 265,
    "Gene name": "EGFR",
    "Genomic Position": "7:55086794-55279321(+)",
    "CDS Mutation": "unspecified_and_ERBB2_unspecified",
    "AA Mutation": "unspecified_and_ERBB2_unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Gefitinib",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT01732276"
  },
  {
    "": 266,
    "Gene name": "EGFR",
    "Genomic Position": "7:55086794-55279321(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Gefitinib",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT01732276"
  },
  {
    "": 267,
    "Gene name": "EGFR",
    "Genomic Position": "7:55086794-55279321(+)",
    "CDS Mutation": "unspecified_or_ERBB2_unspecified",
    "AA Mutation": "unspecified_or_ERBB2_unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Gefitinib",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT01732276"
  },
  {
    "": 268,
    "Gene name": "EGFR",
    "Genomic Position": "7:55086794-55279321(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / basal (triple-negative) carcinoma",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Gefitinib",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT01732276"
  },
  {
    "": 269,
    "Gene name": "ATM",
    "Genomic Position": "11:108093559-108239826(+)",
    "CDS Mutation": "unspecified_or_ATR_unspecified_or_BAP1_unspecified_or_BARD1_unspecified_or_BLM_unspecified_or_BRIP1_unspecified_or_CHEK1_unspecified_or_CDK12_unspecified_or_FANCA_unspecified_or_FANCC_unspecified_or_FANCD2_unspecified_or_FANCE_unspecified_or_FANCF_unspecified_or_FANCM_unspecified_MRE11_unspecified_or_NBN_unspecified_or_PTEN_unspecified_or_RAD50_unspecified_or_RAD51C_unspecified_or_RAD51D_unspecified_or_WRN_unspecified",
    "AA Mutation": "unspecified_or_ATR_unspecified_or_BAP1_unspecified_or_BARD1_unspecified_or_BLM_unspecified_or_BRIP1_unspecified_or_CHEK1_unspecified_or_CDK12_unspecified_or_FANCA_unspecified_or_FANCC_unspecified_or_FANCD2_unspecified_or_FANCE_unspecified_or_FANCF_unspecified_or_FANCM_unspecified_MRE11_unspecified_or_NBN_unspecified_or_PTEN_unspecified_or_RAD50_unspecified_or_RAD51C_unspecified_or_RAD51D_unspecified_or_WRN_unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Olaparib + Pembrolizumab",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT05033756"
  },
  {
    "": 270,
    "Gene name": "ATM",
    "Genomic Position": "11:108093559-108239826(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Olaparib + Pembrolizumab",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT05033756"
  },
  {
    "": 271,
    "Gene name": "ATM",
    "Genomic Position": "11:108093559-108239826(+)",
    "CDS Mutation": "unspecified_or_ATR_unspecified_or_BARD1_unspecified_or_BRCA1_unspecified_or_BRCA2_unspecified_or_BRIP1_unspecified_or_CHEK2_unspecified_or_FANCA_unspecified_or_FANCC_unspecified_or_FANCD2_unspecified_or_FANCE_unspecified_or_FANCF_unspecified_or_FANCM_unspecified_or_MRE11A_unspecified_or_NBN_unspecified_or_PALB2_unspecified_or_RAD50_unspecified_or_RAD51C_unspecified_or_RAD51D_unspecified",
    "AA Mutation": "unspecified_or_ATR_unspecified_or_BARD1_unspecified_or_BRCA1_unspecified_or_BRCA2_unspecified_or_BRIP1_unspecified_or_CHEK2_unspecified_or_FANCA_unspecified_or_FANCC_unspecified_or_FANCD2_unspecified_or_FANCE_unspecified_or_FANCF_unspecified_or_FANCM_unspecified_or_MRE11A_unspecified_or_NBN_unspecified_or_PALB2_unspecified_or_RAD50_unspecified_or_RAD51C_unspecified_or_RAD51D_unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Olaparib + Pembrolizumab",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT05033756"
  },
  {
    "": 272,
    "Gene name": "ATM",
    "Genomic Position": "11:108093559-108239826(+)",
    "CDS Mutation": "unspecified_or_ATR_unspecified_or_BARD1_unspecified_or_BRIP1_unspecified_or_CHEK2_unspecified_or_FANCA_unspecified_or_FANCC_unspecified_or_FANCD2_unspecified_or_FANCE_unspecified_or_FANCF_unspecified_or_FANCG_unspecified_or_FANCL_unspecified_or_MRE11_unspecified_or_NBN_unspecified_or_PALB2_unspecified_or_PTEN_unspecified_or_RAD50_unspecified_or_RAD51C_unspecified_RAD51D_unspecified",
    "AA Mutation": "unspecified_or_ATR_unspecified_or_BARD1_unspecified_or_BRIP1_unspecified_or_CHEK2_unspecified_or_FANCA_unspecified_or_FANCC_unspecified_or_FANCD2_unspecified_or_FANCE_unspecified_or_FANCF_unspecified_or_FANCG_unspecified_or_FANCL_unspecified_or_MRE11_unspecified_or_NBN_unspecified_or_PALB2_unspecified_or_PTEN_unspecified_or_RAD50_unspecified_or_RAD51C_unspecified_RAD51D_unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Olaparib + Pembrolizumab",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT05033756"
  },
  {
    "": 273,
    "Gene name": "ATM",
    "Genomic Position": "11:108093559-108239826(+)",
    "CDS Mutation": "unspecified_or_BARD1_unspecified_or_CHEK2_unspecified_or_FANCC_unspecified_or_PALB2_unspecified_or_RAD51C_unspecified_or_RAD51D_unspecified_or_SLX4_unspecified_or_XRCC2_unspecified",
    "AA Mutation": "unspecified_or_BARD1_unspecified_or_CHEK2_unspecified_or_FANCC_unspecified_or_PALB2_unspecified_or_RAD51C_unspecified_or_RAD51D_unspecified_or_SLX4_unspecified_or_XRCC2_unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Olaparib + Pembrolizumab",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT05033756"
  },
  {
    "": 274,
    "Gene name": "CHEK2",
    "Genomic Position": "22:29083751-29137826(-)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Capecitabine + Platinum-based chemotherapy",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT04335669"
  },
  {
    "": 275,
    "Gene name": "VEGFA",
    "Genomic Position": "6:43738444-43752346(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Vandetanib",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT02299999"
  },
  {
    "": 276,
    "Gene name": "PPP2R2A",
    "Genomic Position": "8:26150732-26228402(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Talazoparib",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT04892693"
  },
  {
    "": 277,
    "Gene name": "ERBB3",
    "Genomic Position": "12:56473645-56497289(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Patritumab deruxtecan",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT02980341"
  },
  {
    "": 278,
    "Gene name": "CCR5",
    "Genomic Position": "3:46411633-46417673(+)",
    "CDS Mutation": "unspecified_and_CD274_unspecified",
    "AA Mutation": "unspecified_and_CD274_unspecified",
    "Disease": "breast / carcinoma / basal (triple-negative) carcinoma",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Carboplatin + Leronlimab",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT03838367"
  },
  {
    "": 279,
    "Gene name": "CHEK1",
    "Genomic Position": "11:125496236-125527031(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Talazoparib",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT04892693"
  },
  {
    "": 280,
    "Gene name": "FGFR3",
    "Genomic Position": "4:1795039-1810599(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Futibatinib",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT04024436"
  },
  {
    "": 281,
    "Gene name": "TACSTD2",
    "Genomic Position": "1:59041099-59043166(-)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Sacituzumab govitecan",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT05332561"
  },
  {
    "": 282,
    "Gene name": "ERBB4",
    "Genomic Position": "2:212240446-213403565(-)",
    "CDS Mutation": "unspecified_and_CD274_unspecified",
    "AA Mutation": "unspecified_and_CD274_unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Cyclophosphamide + Docetaxel + Epirubicin hydrochloride + Nab-paclitaxel + Pyrotinib",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT04872985"
  },
  {
    "": 283,
    "Gene name": "ERBB4",
    "Genomic Position": "2:212240446-213403565(-)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Cyclophosphamide + Docetaxel + Epirubicin hydrochloride + Nab-paclitaxel + Pyrotinib",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT04872985"
  },
  {
    "": 284,
    "Gene name": "ERBB4",
    "Genomic Position": "2:212240446-213403565(-)",
    "CDS Mutation": "unspecified_and_CD274_unspecified",
    "AA Mutation": "unspecified_and_CD274_unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Cyclophosphamide + Docetaxel + Epirubicin hydrochloride + Nab-paclitaxel + Pyrotinib",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT04872985"
  },
  {
    "": 285,
    "Gene name": "MAP2K1",
    "Genomic Position": "15:66679155-66784650(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "PD0325901",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:22402123"
  },
  {
    "": 286,
    "Gene name": "MAP2K1",
    "Genomic Position": "15:66679155-66784650(+)",
    "CDS Mutation": "c.?",
    "AA Mutation": "p.L115P",
    "Disease": "NS",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "PD0325901",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:22402123"
  },
  {
    "": 287,
    "Gene name": "CDK12",
    "Genomic Position": "17:37618292-37691399(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Talazoparib",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT04892693"
  },
  {
    "": 288,
    "Gene name": "RAD54L",
    "Genomic Position": "1:46713404-46744144(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Talazoparib",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT04892693"
  },
  {
    "": 289,
    "Gene name": "ALK",
    "Genomic Position": "2:29415640-30144432(-)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Crizotinib",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT02034981"
  },
  {
    "": 290,
    "Gene name": "BCL2",
    "Genomic Position": "18:60790579-60987361(-)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Letrozole + Palbociclib + Venetoclax",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT03900884"
  },
  {
    "": 291,
    "Gene name": "CD274",
    "Genomic Position": "9:5450525-5470547(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Avelumab",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT02926196"
  },
  {
    "": 292,
    "Gene name": "CD274",
    "Genomic Position": "9:5450525-5470547(+)",
    "CDS Mutation": "unspecified_and_ERBB2_unspecified",
    "AA Mutation": "unspecified_and_ERBB2_unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Avelumab",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT02926196"
  },
  {
    "": 293,
    "Gene name": "CD274",
    "Genomic Position": "9:5450525-5470547(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / basal (triple-negative) carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Avelumab",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT02926196"
  },
  {
    "": 294,
    "Gene name": "CD274",
    "Genomic Position": "9:5450525-5470547(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / basal (triple-negative) carcinoma",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Avelumab",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT02926196"
  },
  {
    "": 295,
    "Gene name": "CD274",
    "Genomic Position": "9:5450525-5470547(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Avelumab",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT02926196"
  },
  {
    "": 296,
    "Gene name": "NF1",
    "Genomic Position": "17:29421945-29704695(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Famitinib + SHR7390",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT04355858"
  },
  {
    "": 297,
    "Gene name": "RAD51B",
    "Genomic Position": "14:68286525-69062713(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Talazoparib",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT04892693"
  },
  {
    "": 298,
    "Gene name": "ROS1",
    "Genomic Position": "6:117609463-117747018(-)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Crizotinib + Fulvestrant",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT03620643"
  },
  {
    "": 299,
    "Gene name": "FANCL",
    "Genomic Position": "2:58386382-58468485(-)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Talazoparib",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT04892693"
  },
  {
    "": 300,
    "Gene name": "MTOR",
    "Genomic Position": "1:11166592-11322564(-)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Rapamycin",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:27279227"
  },
  {
    "": 301,
    "Gene name": "MTOR",
    "Genomic Position": "1:11166592-11322564(-)",
    "CDS Mutation": "c.?",
    "AA Mutation": "p.F2108L",
    "Disease": "NS",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Rapamycin",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:27279227"
  },
  {
    "": 302,
    "Gene name": "RET",
    "Genomic Position": "10:43572475-43625799(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Lenvatinib",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT03168074"
  },
  {
    "": 303,
    "Gene name": "WT1",
    "Genomic Position": "11:32409321-32457176(-)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Galinpepimut-S + Pembrolizumab + Sargramostim",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT03761914"
  },
  {
    "": 304,
    "Gene name": "WT1",
    "Genomic Position": "11:32409321-32457176(-)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / basal (triple-negative) carcinoma",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Galinpepimut-S + Pembrolizumab + Sargramostim",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT03761914"
  },
  {
    "": 305,
    "Gene name": "RAD51D",
    "Genomic Position": "17:33427691-33446832(-)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Capecitabine + Platinum-based chemotherapy",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT04335669"
  },
  {
    "": 306,
    "Gene name": "PDGFRB",
    "Genomic Position": "5:149493400-149535423(-)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Famitinb",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT04355858"
  },
  {
    "": 307,
    "Gene name": "NT5E",
    "Genomic Position": "6:86159809-86205496(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / basal (triple-negative) carcinoma",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Carboplatin + Durvalumab + Oleclumab + Paclitaxel",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT03616886"
  },
  {
    "": 308,
    "Gene name": "KRAS",
    "Genomic Position": "12:25362365-25403737(-)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Paclitaxel + Pelareorep",
    "Description": "",
    "rs value": "",
    "pmid": "Corporate website:NCT01656538"
  },
  {
    "": 309,
    "Gene name": "KRAS",
    "Genomic Position": "12:25362365-25403737(-)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Paclitaxel + Pelareorep",
    "Description": "",
    "rs value": "",
    "pmid": "Corporate website:NCT01656538"
  },
  {
    "": 310,
    "Gene name": "RAD51C",
    "Genomic Position": "17:56769934-56811703(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Capecitabine + Platinum-based chemotherapy",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT04335669"
  },
  {
    "": 311,
    "Gene name": "BRIP1",
    "Genomic Position": "17:59758627-59940882(-)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Talazoparib",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT04892693"
  },
  {
    "": 312,
    "Gene name": "PALB2",
    "Genomic Position": "16:23614491-23652631(-)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "breast / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Capecitabine + Platinum-based chemotherapy",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT04335669"
  },
  {
    "": 313,
    "Gene name": "MAP2",
    "Genomic Position": "2:210444145-210598842(+)",
    "CDS Mutation": "c.?",
    "AA Mutation": "p.L115P",
    "Disease": "NS",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "PD0325901",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:22402123"
  },
  {
    "": 314,
    "Gene name": "MET",
    "Genomic Position": "7:116312459-116436396(+)",
    "CDS Mutation": "c.3682G>A",
    "AA Mutation": "p.D1228N",
    "Disease": "basal_(triple-negative)_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Crizotinib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:32234363"
  },
  {
    "": 315,
    "Gene name": "MET",
    "Genomic Position": "7:116312459-116436396(+)",
    "CDS Mutation": "c.3736G>A",
    "AA Mutation": "p.D1246N",
    "Disease": "basal_(triple-negative)_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Crizotinib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:32234363"
  }
]